Seres Therapeutics (MCRB) Non Operating Investment Income (2025 - 2026)
Seres Therapeutics' Non Operating Investment Income came in at $25 million for Q2 2026, compared with $185,000 a year earlier.
Seres Therapeutics (MCRB) Non Operating Investment Income (2025 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Seres Therapeutics reported Non Operating Investment Income of $27.37 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Seres Therapeutics | 20.54 Mn | -118.29 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.00 Mn |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 2.18 Mn |
Seres Therapeutics Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=MCRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();